Showing results (1401-1410 of 1,457) with videos related to
Sort By:
Pageof 146
The Journal of Clinical Investigation|July 3, 2023
Human endogenous retrovirus K contributes to a stem cell niche in glioblastomaAshish H Shah, Sarah R Rivas, Tara T Doucet-O'Hare, et al.American Journal of Human Genetics|October 22, 2019
RPL13 Variants Cause Spondyloepimetaphyseal Dysplasia with Severe Short StatureCedric Le Caignec, Benjamin Ory, François Lamoureux, et al.Med (New York, N.Y.)|December 13, 2022
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeGal Dinstag, Eldad D Shulman, Efrat Elis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001Paul D Brown, Vinai Gondi, Stephanie Pugh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade GliomaErica H Bell, Peixin Zhang, Edward G Shaw, et al.AJNR. American Journal of Neuroradiology|June 26, 2024
A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in AdultsBenjamin M Ellingson, Francesco Sanvito, Timothy F Cloughesy, et al.The Journal of Biological Chemistry|May 29, 1999
Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variantsL G Czaplewski, J McKeating, C J Craven, et al.Cancer Discovery|April 27, 2013
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkersVivian W Y Lui, Matthew L Hedberg, Hua Li, et al.Neuro-Oncology|April 28, 2025
Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiativeOgechukwu A Asogwa, Linda Dirven, Tobias Walbert, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Central nervous system cancersLouis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.Pageof 146